| Jul 1 2020 |
EFSA Prioritizes Substances without an SML for Re-evaluation |
Keller and Heckman LLP |
| Jul 1 2020 |
Class of End-Payors Certified in Illegal Monopolization Suit Against Drug Maker Allergan |
MoginRubin |
| Jul 1 2020 |
Federal Judge Denies Plant-Based “Butter” Motion to Dismiss |
Keller and Heckman LLP |
| Jun 30 2020 |
Compensation Considerations for Emerging Biotech and Life Sciences Companies |
Jones Walker LLP |
| Jun 30 2020 |
Ninth Circuit’s Ingredients List Rule Keeps Nestlé in Hot Water with Denial of Nestlé’s Statute of Limitations-Based Summary Judgment Motion |
Faegre Drinker |
| Jun 30 2020 |
Cosmetics Sold in California are Set for a Face Lift |
Hunton Andrews Kurth |
| Jun 30 2020 |
Insurers Have Duty to Defend Opioid Cases According to Ohio Appellate Court |
Hunton Andrews Kurth |
| Jun 30 2020 |
CDC and OSHA Issue Guidance for Sea Food Processors During the COVID-19 Pandemic |
Keller and Heckman LLP |
| Jun 30 2020 |
Ohio Appellate Court Rules That Insurer Must Defend Party Involved In Opioid MDL |
Barnes & Thornburg LLP |
| Jun 30 2020 |
Federal Circuit Focuses On Active Ingredient, Not Active Moiety, For Scope Of Patent Term Extension |
Foley & Lardner LLP |
| Jun 29 2020 |
A Budding Challenge for Employers? Louisiana Expands Access to Medical Marijuana |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jun 29 2020 |
Vermont’s Plastic Bag Ban Takes Effect July 1; Other States Push Back on Bans |
Keller and Heckman LLP |
| Jun 29 2020 |
Pennsylvania Governor Issues Additional Updated Guidance for Hospitality Businesses Conducting In-Person Service (Second Update) |
Norris McLaughlin P.A. |
| Jun 29 2020 |
Current Good Manufacturing Practices in the Time of COVID-19: FDA Announces New Expectations on Risk Assessment and Risk Management |
Epstein Becker & Green, P.C. |
| Jun 27 2020 |
Non-Alcoholic Beer Regulation 101 |
McDermott Will & Schulte LLP |
| Jun 26 2020 |
NIOSH Publishes Program Performance One-Pager for Nanotechnology Research Center |
Bergeson & Campbell, P.C. |
| Jun 26 2020 |
Court Bars CA Prop 65 Glyphosate Warning Requirement |
Keller and Heckman LLP |
| Jun 26 2020 |
Its High Time: Will Somebody Please Tell the Cannabis Industry about the TCPA Already? |
Troutman Amin, LLP |
| Jun 26 2020 |
California Federal Judge Enters Permanent Injunction Barring Enforcement of Prop. 65 Cancer Warning for Glyphosate as Unconstitutional Compelled Speech |
Keller and Heckman LLP |
| Jun 26 2020 |
CMS Proposes Rule to Pave the Way for Value-Based Drug Purchasing |
Mintz |
| Jun 26 2020 |
Market Entry and Real World Data – China’s Medical Device Industry |
K&L Gates LLP |
| Jun 25 2020 |
Final Risk Evaluation for Methylene Chloride Is First Completed under Lautenberg Act Amendments |
Bergeson & Campbell, P.C. |
| Jun 25 2020 |
The Perpetuation of Class-Action Forum Shopping? Federal Circuits Address Whether Courts Need Personal Jurisdiction to Hear Nationwide Class Actions |
Greenberg Traurig, LLP |
| Jun 25 2020 |
US Trademark Office Waives/Refunds Fees for Reviving Applications and Registrations Abandoned Due to COVID-19 |
Dinsmore & Shohl LLP |
| Jun 25 2020 |
Band Together: Corporate and Cultural Convergence in Life Sciences M&A |
Mintz |
| Jun 25 2020 |
EPA Publishes Final Risk Evaluation for Methylene Chloride |
Bergeson & Campbell, P.C. |
| Jun 25 2020 |
EPA Orders OCCS, Inc. to Stop Sales of Unregistered Antimicrobial Disinfectant Products |
Bergeson & Campbell, P.C. |
| Jun 24 2020 |
New Florida Legislation Expands Pharmacist Scope of Practice |
Greenberg Traurig, LLP |
| Jun 24 2020 |
Citizen’s Petition Filed for FDA Pathway to Legally Market Supplements With CBD |
Faegre Drinker |
| Jun 24 2020 |
If you Handle PFAS, Your TRI May Be Different Next Year |
Beveridge & Diamond PC |
| Jun 24 2020 |
California Judge Dismisses Proposed Class Action Against Kellogg Vanilla Labeling |
Keller and Heckman LLP |
| Jun 23 2020 |
Ninth Circuit Rejects Plaintiffs’ Claims in Trio of ADA Disability Access Cases |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jun 23 2020 |
Update on FDA’s Comprehensive Regenerative Medicine Framework: Looming November 2020 Deadline Preceded by a Flurry of Letters from CBER and a New JAMA Editorial |
Mintz |
| Jun 23 2020 |
FDA Adds QR Code to Certain Food Export Certificates |
Keller and Heckman LLP |
| Jun 23 2020 |
FDA Issue Guidance on Manufacturing Drugs, APIs during COVID-19 |
Sheppard, Mullin, Richter & Hampton LLP |
